Sundial Growers Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sundial Growers in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Sundial Growers stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SNDL, but not buy additional shares or sell existing shares.
View analyst ratings for Sundial Growers or view top-rated stocks.

3 brokerages have issued 12-month target prices for Sundial Growers' stock. Their SNDL stock forecasts range from $0.70 to $0.70. On average, they predict Sundial Growers' share price to reach $0.70 in the next year. This suggests a possible upside of 103.9% from the stock's current price.
View analysts' price targets for Sundial Growers or view top-rated stocks among Wall Street analysts.

Sundial Growers' stock was trading at $0.5780 on January 1st, 2022. Since then, SNDL shares have decreased by 40.6% and is now trading at $0.3433.
View the best growth stocks for 2022 here.

Sundial Growers is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Sundial Growers.

Sundial Growers Inc. (NASDAQ:SNDL) posted its quarterly earnings data on Friday, May, 15th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.16. The business had revenue of $23.04 million for the quarter. Sundial Growers had a negative trailing twelve-month return on equity of 3.94% and a negative net margin of 210.98%.
View Sundial Growers' earnings history.

3 employees have rated Sundial Growers CEO Torsten Kuenzlen on Glassdoor.com. Torsten Kuenzlen has an approval rating of 30% among Sundial Growers' employees. This puts Torsten Kuenzlen in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Sundial Growers include Tilray (TLRY), USANA Health Sciences (USNA), Cronos Group (CRON), Canopy Growth (CGC), Cresco Labs (CRLBF), Canopy Rivers (RIV), True Drinks (TRUU), Ascend Wellness (AAWH), Ayr Wellness (AYRWF), Bright Green (BGXX), Aurora Cannabis (ACB), Mind Medicine (MindMed) (MNMD), MariMed (MRMD), biote (BTMD) and ChromaDex (CDXC).
View all of SNDL's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sundial Growers investors own include (CGC), OrganiGram (OGI), (HEXO), Aurora Cannabis (ACB), Genius Brands International (GNUS), Onconova Therapeutics (ONTX), Top Ships (TOPS), (APHA), Cronos Group (CRON) and Sorrento Therapeutics (SRNE).

(SNDL) raised $130 million in an IPO on Thursday, August 1st 2019. The company issued 10,000,000 shares at $12.00-$14.00 per share. Cowen, BMO Capital Markets and Barclays served as the underwriters for the IPO.

Sundial Growers trades on the NASDAQ under the ticker symbol "SNDL."

Shares of SNDL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SNDL stock can currently be purchased for approximately $0.34.

Sundial Growers (NASDAQ:SNDL) has a market capitalization of $569.96 million and generates $44.78 million in revenue each year. The company earns $-183,820,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis.

Sundial Growers employs 394 workers across the globe.

Sundial Growers' mailing address is 919 11 AVENUE SW SUITE 200, CALGARY A0, T2R1P3. The official website for Sundial Growers is www.sundialcannabis.com. The company can be reached via phone at (844) 249-6746 or via email at jmoss@sundialgrowers.com.